A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
This purpose of the study is to investigate if budesonide pMDI 160 �g twice a day during 6
weeks is effective and safe in treating asthmatic children aged 6 to <12 years